|
|
|
Corporate Profile: Heat Biologics
| Summary: |
Heat Biologics is focused on the research and development of its proprietary ImPACT (Immune Pan-Antigen Cytotoxic Therapy) technology platform to treat cancers and infectious diseases.
|
| Address (HQ): |
801 Capitola Drive
Durham, NC 27713 |
| Phone #'s (HQ): |
| Main |
(919) 240-7133 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
info@heatbio.com |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| HTBX |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
